201 results on '"Giudicessi, John R."'
Search Results
2. Sudden cardiac arrest occurring in temporal proximity to consumption of energy drinks
3. Novel risk predictor of arrhythmias for patients with potassium channel–related congenital long QT syndrome
4. Frequency of and outcomes associated with nonadherence to guideline-based recommendations for an implantable cardioverter-defibrillator in patients with congenital long QT syndrome
5. Arrhythmic prognosis according to left ventricular systolic dysfunction severity in cardiac sarcoidosis
6. Injectable contraceptive Depo-Provera induces erratic beating patterns in patient-specific induced pluripotent stem cell–derived cardiomyocytes with long QT syndrome type 2
7. Functional characterization and identification of a therapeutic for a novel SCN5A-F1760C variant causing type 3 long QT syndrome refractory to all guideline-directed therapies
8. Spectrum and prevalence of side effects and complications with guideline-directed therapies for congenital long QT syndrome
9. Genome sequencing in a genetically elusive multigenerational long QT syndrome pedigree identifies a novel LQT2-causative deeply intronic KCNH2 variant
10. Patient-specific, re-engineered cardiomyocyte model confirms the circumstance-dependent arrhythmia risk associated with the African-specific common SCN5A polymorphism p.S1103Y: Implications for the increased sudden deaths observed in black individuals during the COVID-19 pandemic
11. A phenotype-enhanced variant classification framework to decrease the burden of missense variants of uncertain significance in type 1 long QT syndrome
12. Role of chronic continuous intravenous lidocaine in the clinical management of patients with malignant type 3 long QT syndrome
13. Purkinje system hyperexcitability and ventricular arrhythmia risk in type 3 long QT syndrome
14. Clinical and functional reappraisal of alleged type 5 long QT syndrome: Causative genetic variants in the KCNE1-encoded minK β-subunit
15. Utilization of the genome aggregation database, in silico tools, and heterologous expression patch-clamp studies to identify and demote previously published type 2 long QT syndrome: Causative variants from pathogenic to likely benign
16. Incidence of Newly Recognized Atrial Fibrillation in Patients with Obstructive Hypertrophic Cardiomyopathy Treated with Mavacamten
17. Return to work for patients in high-risk professions diagnosed with a sudden cardiac death–predisposing genetic heart disease
18. Exercise testing oversights underlie missed and delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia in young sudden cardiac arrest survivors
19. Long QT syndrome type 5-Lite: Defining the clinical phenotype associated with the potentially proarrhythmic p.Asp85Asn-KCNE1 common genetic variant
20. BS-452759-1 SPATIAL CLUSTERING ANALYSIS HIGHLIGHTS DISEASE-SPECIFIC 3-DIMENSIONAL DISTRIBUTION OF PATHOGENIC VARIANTS IN THE -ENCODED NAV1.5 CARDIAC SODIUM CHANNEL
21. PO-03-231 BREAKTHROUGH CARDIAC EVENT RATE OF INITIALLY ASYMPTOMATIC LQTS PATIENTS
22. PO-455617-20 PREDICTORS FOR SUDDEN CARDIAC DEATH AND SUSTAINED VENTRICULAR ARRHYTHMIAS AMONG HIGH-RISK PATIENTS WITH ARRHYTHMOGENIC MITRAL VALVE PROLAPSE SYNDROME
23. PO-02-142 MIRNA DOWN-REGULATE HYPERTROPHY AND INFLAMMATORY PATHWAYS IN THE TRANSCRIPTOME OF HYPERTROPHIC CARDIOMYOPATHY MYECTOMY TISSUE
24. CE-452775-1 PREDICTORS FOR SUDDEN CARDIAC DEATH AND SUSTAINED VENTRICULAR ARRHYTHMIAS AMONG HIGH-RISK PATIENTS WITH ARRHYTHMOGENIC MITRAL VALVE PROLAPSE SYNDROME
25. PO-03-156 SPECTRUM AND PREVALENCE OF RYR2-OPATHIES DURING LIFE AND AFTER SUDDEN DEATH
26. Unraveling the influence of genomic context on pleiotropy in SCN5A-mediated cardiac channelopathies: Insights from the Worm Study
27. PO-04-194 PROGNOSTIC SIGNIFICANCE OF ELECTROPHYSIOLOGIC TESTING FOR VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH MITRAL ANNULAR DISJUNCTION
28. PO-04-105 ELUCIDATION OF THE PREVALENCE, SPECTRUM, AND OUTCOMES IN PATIENTS WITH NON-PENETRANT LONG QT SYNDROME
29. PO-01-240 UTILITY OF FUNCTIONAL CHARACTERIZATION IN THE PROMOTION OR DEMOTION OF CLINICALLY ENCOUNTERED VARIANTS OF UNCERTAIN SIGNIFICANCE IN THE THREE MOST COMMON LONG QT SYNDROME-CAUSATIVE GENES: , KCNH, AND
30. PO-04-143 CARDIOVASCULAR OUTCOMES IN -MEDIATED CARDIAC LAMINOPATHY: THE MAYO CLINIC EXPERIENCE
31. PO-04-159 PREVALENCE AND CHARACTERISTICS OF PATIENTS WITH LONG QT SYNDROME (LQTS) WHO APPEAR NON-RESPONSIVE TO CONVENTIONAL LQTS THERAPIES
32. PO-04-125 SPECTRUM, PREVALENCE, AND IMPLICATIONS OF INCIDENTAL VARIANT FINDINGS IN CARDIAC DISEASE-ASSOCIATED GENES DURING PREVENTATIVE GENETIC TESTING
33. Allergy therapy for patients with a cardiac channelopathy: Do not withhold lifesaving treatments
34. Long QT syndrome, pregnancy, and nonselective β-blockers: Efficacious for mom and safe for baby?
35. PO-630-04 ELUCIDATION OF ALG10B AS A NOVEL LONG QT SYNDROME SUSCEPTIBILITY GENE
36. PO-625-02 SODIUM CHANNEL BLOCKER MONOTHERAPY IN PATIENTS WITH CONGENITAL LONG QT SYNDROME
37. PO-629-04 PHENOTYPES OF OVERDIAGNOSED LONG QT SYNDROME
38. PO-615-05 ACACETIN, A POTENT TRANSIENT OUTWARD CURRENT BLOCKER, MAY BE A NOVEL THERAPEUTIC FOR KCND3-ENCODED KV4.3 GAIN-OF-FUNCTION-ASSOCIATED J-WAVE SYNDROMES
39. PO-629-02 NEW EVIDENCE TO CHALLENGE CLINGEN'S “DISPUTED EVIDENCE” DESIGNATION FOR AKAP9 AS A BONA FIDE SUSCEPTIBILITY GENE FOR CONGENITAL LONG QT SYNDROME
40. PO-704-02 VAPING-ASSOCIATED SUDDEN DEATH IN THE YOUNG
41. PO-06-083 VENTRICULAR ARRHYTHMIC RISK IN CARDIAC SARCOIDOSIS PATIENTS WITH SYSTOLIC HEART FAILURE AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
42. PO-06-051 “MAD” ARRHYTHMIA COMPLEXITY: A MATCHED CONTROLLED STUDY OF VENTRICULAR ARRHYTHMIA MARKERS AND CHARACTERISTICS IN PATIENTS WITH MITRAL VALVE PROLAPSE WITH AND WITHOUT MITRAL ANNULAR DISJUNCTION
43. PO-05-011 CLINICAL UTILITY OF PROTEIN LANGUAGE MODELS IN RESOLUTION OF VARIANTS OF UNCERTAIN SIGNIFICANCE IN KCNQ1, KCNH2, AND SCN5A COMPARED TO PATCH CLAMP FUNCTIONAL CHARACTERIZATION
44. PO-05-003 EMPAGLIFLOZIN SHORTENED THE PROLONGED ACTION POTENTIAL DURATION IN HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES WITH THIN FILAMENT HYPERTROPHIC CARDIOMYOPATHY
45. PO-04-001 OUTCOMES OF PATIENTS SUBSEQUENTLY DIAGNOSED WITH CONGENITAL LONG QT SYNDROME AFTER PRESENTING WITH A SENTINEL EVENT OF SUDDEN CARDIAC ARREST
46. PO-04-071 OUTCOMES OF CATHETER ABLATION OF ATRIAL FIBRILLATION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AND PRIOR SURGICAL MYECTOMY
47. PO-02-089 AN EXAMINATION OF GUIDELINE-DIRECTED DEVICE THERAPY WITH AN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR FOR LONG QT SYNDROME
48. PO-02-090 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR THERAPY FOR CHANNELOPATHIES: A SINGLE CENTER EXPERIENCE
49. PO-01-040 TRIGGER TYPE AND SUBSEQUENT BREAKTHROUGH CARDIAC EVENTS IN PATIENTS WITH EITHER LONG QT SYNDROME OR CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA AFTER LEFT CARDIAC SYMPATHETIC DENERVATION
50. PO-01-075 ROLE OF GENOTYPE IN RISK PREDICTION FOR ARRHYTHMOGENIC CARDIOMYOPATHIES
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.